Spots Global Cancer Trial Database for entecavir
Every month we try and update this database with for entecavir cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients | NCT01907230 | Rheumatoid Arth... Hepatitis B Rea... Exposure to Hep... | Entecavir | 20 Years - 90 Years | Taipei Veterans General Hospital, Taiwan | |
| Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer | NCT00824707 | Primary Liver C... | Entecavir conventional th... | 18 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | |
| Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody) | NCT05453435 | Resolved Hepati... CD20 Positive B... | Entecavir | 18 Years - | Sun Yat-sen University | |
| Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors | NCT03887702 | Hepatitis B Inf... Malignant Solid... | Best Practice Entecavir Tenofovir Alafe... Tenofovir Disop... | 18 Years - | SWOG Cancer Research Network | |
| Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B Carriers | NCT02777801 | Stomach Neoplas... | Entecavir | 18 Years - 75 Years | Sun Yat-sen University | |
| Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL | NCT01914744 | Non-Hodgkin Lym... Hepatitis B Rea... | Entecavir Lamivudine | 18 Years - 80 Years | Fudan University | |
| Incidence of Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients | NCT00931229 | Non-Hodgkin's L... | entecavir | 18 Years - 75 Years | National Health Research Institutes, Taiwan | |
| Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection | NCT01018381 | Hepatocellular ... Hepatitis B | PEIT TOCE TOCE plus PEIT TOCE plus RFA MGN-3 Entecavir | 30 Years - 70 Years | The 108 Military Central Hospital | |
| Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL | NCT01914744 | Non-Hodgkin Lym... Hepatitis B Rea... | Entecavir Lamivudine | 18 Years - 80 Years | Fudan University | |
| Incidence of Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients | NCT00931229 | Non-Hodgkin's L... | entecavir | 18 Years - 75 Years | National Health Research Institutes, Taiwan | |
| Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation Therapy | NCT01270178 | Chronic Hepatit... Hepatocellular ... | Entecavir | 20 Years - | Taipei Veterans General Hospital, Taiwan | |
| Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis | NCT04160897 | Hepatitis B, Ch... Hepatocellular ... Compensated Cir... | Entecavir Tenofovir Disop... | 18 Years - 80 Years | Ruijin Hospital | |
| Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection | NCT01018381 | Hepatocellular ... Hepatitis B | PEIT TOCE TOCE plus PEIT TOCE plus RFA MGN-3 Entecavir | 30 Years - 70 Years | The 108 Military Central Hospital | |
| Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC | NCT02650271 | Hepatocellular ... | Entecavir Tenofovir | 18 Years - 75 Years | Guangxi Medical University | |
| Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B Carriers | NCT02777801 | Stomach Neoplas... | Entecavir | 18 Years - 75 Years | Sun Yat-sen University | |
| Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC | NCT02650271 | Hepatocellular ... | Entecavir Tenofovir | 18 Years - 75 Years | Guangxi Medical University | |
| Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B Carriers | NCT02777801 | Stomach Neoplas... | Entecavir | 18 Years - 75 Years | Sun Yat-sen University | |
| Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine | NCT01580202 | Malignancy Hepatitis B | Entecavir Lamivudine | 18 Years - | Seoul National University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
